GEMINI THERAPEUTICSCS INC

Share · US36870G1058 · GMTX (XNAS)

No Price

n/a

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	0,00 %	0,00 %	-88,84 %

Company Profile for GEMINI THERAPEUTICSCS INC Share

Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Company Data

Name GEMINI THERAPEUTICSCS INC

Company Gemini Therapeutics, Inc.

Symbol GMTX

Website https://www.geminitherapeutics.com

Primary Exchange

NASDAQ

ISIN US36870G1058

Asset Class Share

Sector Healthcare

Industry Biotechnology

Market Capitalization 25 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 300 One Kendall Square, 02139 Cambridge

IPO Date 2020-08-12

Stock Splits

Date	Split
30.12.2022	1:10

Ticker Symbols

Name	Symbol
NASDAQ	GMTX

More Shares

Investors who hold GEMINI THERAPEUTICSCS INC also have the following shares in their portfolio:

AMGEN INC Share

ASGN INC Share

ATH. MEDIC.CENTER EO 0,34 Share

AUTODESK INC Share

CISCO SYSTEMS INC Share

COMCAST CORP - CLASS A Share

COSTCO WHOLESALE CORP Share

IDEXX LABORATORIES INC Share

INTEL CORP Share

MICROSOFT CORP Share

ORIC PHARMACEUTICALS INC Share

QIAGEN NV (alt) Share

SDV 2025 ZDP PLC - ZDP SHS 100P Share

WALGREENS BOOTS ALLIANCE INC Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog